Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Margherita Torti"'
Autor:
Maria Francesca De Pandis, Margherita Torti, Rossella Rotondo, Lanfranco Iodice, Maria Levi Della Vida, Miriam Casali, Laura Vacca, Fabio Viselli, Valeria Servodidio, Stefania Proietti, Fabrizio Stocchi
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundIn 1997 the European Parkinson’s Disease Associations launched the Charter for People with Parkinson’s disease that stated the right of patients to be informed and trained on the disease, its course, and treatments available. To date, f
Externí odkaz:
https://doaj.org/article/4e5511b5df424571abda211448a22525
Autor:
Margherita Torti, Chiara Fossati, Miriam Casali, Maria Francesca De Pandis, Paola Grassini, Fabiana Giada Radicati, Paola Stirpe, Laura Vacca, Ivo Iavicoli, Veruscka Leso, Marcello Ceppi, Marco Bruzzone, Stefano Bonassi, Fabrizio Stocchi
Publikováno v:
PLoS ONE, Vol 15, Iss 12, p e0243612 (2020)
BackgroundThe aetiology of Parkinson's disease (PD) is still very controversial, with a peculiar lack of established risk factors or protective behavior.MethodsWe carried out a case-control study of 634 idiopathic PD patients admitted from 2011 to 20
Externí odkaz:
https://doaj.org/article/2f26524de770433aa03a37befa796a18
Autor:
Fabrizio Stocchi, Laura Vacca, Paola Grassini, Stephen Pawsey, Holly Whale, Stefano Marconi, Margherita Torti
Publikováno v:
Parkinson's Disease, Vol 2015 (2015)
Objectives. To characterize the pharmacokinetic profile of levodopa (L-dopa) and carbidopa after repeated doses of the effervescent tablet of melevodopa/carbidopa (V1512; Sirio) compared with standard-release L-dopa/carbidopa in patients with fluctua
Externí odkaz:
https://doaj.org/article/6ee4b316834c4da7b59d9329b29a8da6
Autor:
Sabrina, Paganoni, James D, Berry, Melanie, Quintana, Eric, Macklin, Benjamin R, Saville, Michelle A, Detry, Marianne, Chase, Alexander V, Sherman, Hong, Yu, Kristin, Drake, Jinsy, Andrews, Jeremy, Shefner, Lori B, Chibnik, Matteo, Vestrucci, Merit E, Cudkowicz, Margherita, Torti
Publikováno v:
Annals of Neurology. 91:165-175
Current therapeutic development in amyotrophic lateral sclerosis (ALS) relies on individual randomized clinical trials to test a specific investigational product in a single patient population. This approach has intrinsic limitations, including cost,
Publikováno v:
Expert Opinion on Pharmacotherapy. 22:965-972
Introduction : Levodopa is the most effective drug in the treatment of Parkinson's disease, but its chronic treatment is linked to the occurrence of motor complications with fluctuations of motor performance and dyskinesia. Unpredictable OFF episodes
Publikováno v:
Expert Opinion on Drug Safety. 19:1155-1172
Nonergot dopamine agonists (NEDA) represent an excellent treatment option for Parkinson's disease (PD) patients, in both early and advanced stages of the disease. The post-marketing phase of NEDA has highlighted, though, the occurrence of important l
Publikováno v:
Drugs. 79:693-703
Dopamine agonists (DAs) represent an excellent treatment option for patients with Parkinson's disease, in both the early and advanced stages of the disease, improving motor symptoms, lowering the incidence of motor complications, and addressing sever
Effect of family history, occupation and diet on the risk of Parkinson disease: A case-control study
Autor:
Marco Bruzzone, Maria Francesca De Pandis, Miriam Casali, Chiara Fossati, Ivo Iavicoli, Stefano Bonassi, Marcello Ceppi, Paola Grassini, Fabiana Giada Radicati, Fabrizio Stocchi, Laura Vacca, Margherita Torti, Paola Stirpe, Veruscka Leso
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0243612 (2020)
PLoS ONE, Vol 15, Iss 12, p e0243612 (2020)
Background The aetiology of Parkinson’s disease (PD) is still very controversial, with a peculiar lack of established risk factors or protective behavior. Methods We carried out a case–control study of 634 idiopathic PD patients admitted from 201
Autor:
Margherita Torti, Carlo Tomino, Maurizio Volterrani, Giuseppe Caminiti, Valentino D'Antoni, Laura Vacca, Fabrizio Stocchi, Miriam Casali, Paola Grassini
Publikováno v:
European journal of neurologyReferences. 28(1)
Background and purpose When switching between monoamine oxidase type B (MAO-B) inhibitors, a 15-day suspension period is a precautionary measure to avoid a serotonin syndrome and hypertensive crisis. However, this indication results in a major inconv
Autor:
Andrea Quagliariello, Paola Grassini, Alessandra Russo, Sofia Reddel, Margherita Torti, Federica Del Chierico, Fabrizio Stocchi
Background: There is increasing evidence of the association between microbiome dysfunction and Parkinson’s disease (PD). Moreover, some PD patients suffer from unintentional weight loss (WL) which may precede the motor manifestations of the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::394c48c44918b3a44459c3c7ead2228a
http://hdl.handle.net/11577/3420747
http://hdl.handle.net/11577/3420747